CHIPIN

CHIPIN normalizes ChIP-seq signal across experimental conditions by leveraging gene expression data to identify regulatory regions with stable expression and derive normalization factors when spike-in controls are unavailable.

Key Features:

• Normalization Technique: Leverages gene expression data and the assumption that regulatory regions of genes with constant expression exhibit no ChIP-seq signal differences to derive normalization factors.
• Versatility: Applicable to ChIP-seq, ATAC-seq, and DNase hypersensitivity datasets for cross-condition signal normalization.
• Output and Analysis Tools: Produces graphical outputs and statistical analyses to evaluate normalization efficiency and to assess antibody specificity.
• Validation and Performance: Validated across multiple ChIP-seq datasets and reported to outperform several commonly used normalization techniques.

Scientific Applications:

• Differential binding analysis: Enables accurate comparison of ChIP-seq signals between experimental conditions for differential binding or occupancy studies.
• Studies of gene modulation and drug treatments: Supports analysis of how gene perturbations or pharmacological treatments affect protein-DNA binding and chromatin structure.
• Chromatin accessibility normalization: Provides normalization for ATAC-seq and DNase hypersensitivity data in experiments lacking spike-in controls.
• Antibody specificity assessment: Facilitates assessment of antibody specificity via statistical evaluation of normalized signals.

Methodology:

Uses gene expression data to identify regulatory regions with constant expression across conditions and uses those regions as references to normalize ChIP-seq signals, avoiding spike-in controls.